ARCHIVES

FDA Says Bristol’s UFT “Not Approvable” For Colorectal Cancer, Contrary To ODAC.

This article is from The Cancer Letter archive.

Vol. 27 No. 13 | March 30, 2001

Download PDF Visit The Full Archive

Related Articles

Senate Committee Approves Additional $400 Million For NCI, $275 Million For FDA.

May 16, 2008

HHS Forms Rural Task Force To Study, Improve Programs.

July 27, 2001

Sorafenib Targets AML Driven By Mutant FLT3 Gene

February 29, 2008

Morale, Money Woes Hit MD Anderson

January 18, 2013

In Brief: Reagan/Congress Budget Compromise Seems Likely, Would Loosen FY 1982 Spending Limits On NCI

December 11, 1981

Peers Puzzled By Herberman’s Stance On Cell Phones While Believers Rally.

August 1, 2008